Justin Zelin
Stock Analyst at BTIG
(1.61)
# 3,487
Out of 5,132 analysts
45
Total ratings
27.27%
Success rate
-9.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $6 → $9 | $5.95 | +51.39% | 2 | Jan 23, 2026 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $45 | $22.46 | +100.36% | 1 | Dec 10, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $56 | $20.48 | +173.44% | 5 | Dec 9, 2025 | |
| AAPG Ascentage Pharma Group International | Initiates: Buy | $50 | $23.72 | +110.79% | 1 | Nov 10, 2025 | |
| TCRX TScan Therapeutics | Downgrades: Neutral | n/a | $0.93 | - | 2 | Nov 4, 2025 | |
| IPHA Innate Pharma | Reiterates: Buy | $8 | $1.76 | +355.84% | 1 | Oct 29, 2025 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $62 | $30.27 | +104.82% | 3 | Oct 21, 2025 | |
| CAN Canaan | Reiterates: Buy | $8 | $0.49 | +1,530.66% | 1 | Oct 14, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $125 | $29.00 | +331.03% | 5 | Sep 22, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Buy | $20 → $7 | $1.14 | +514.04% | 3 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.82 | +243.64% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $26.72 | +57.19% | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.39 | - | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $0.87 | +91,422.71% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $91 | $32.28 | +181.91% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $160 | $6.91 | +2,215.48% | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.98 | +708.08% | 1 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $17.58 | +411.95% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $31 | $8.31 | +273.04% | 1 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $16 | $49.57 | -68.73% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $10 | $0.85 | +1,076.47% | 3 | Nov 16, 2022 |
ImmunityBio
Jan 23, 2026
Maintains: Buy
Price Target: $6 → $9
Current: $5.95
Upside: +51.39%
ArriVent BioPharma
Dec 10, 2025
Initiates: Buy
Price Target: $45
Current: $22.46
Upside: +100.36%
Syndax Pharmaceuticals
Dec 9, 2025
Reiterates: Buy
Price Target: $56
Current: $20.48
Upside: +173.44%
Ascentage Pharma Group International
Nov 10, 2025
Initiates: Buy
Price Target: $50
Current: $23.72
Upside: +110.79%
TScan Therapeutics
Nov 4, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.93
Upside: -
Innate Pharma
Oct 29, 2025
Reiterates: Buy
Price Target: $8
Current: $1.76
Upside: +355.84%
IDEAYA Biosciences
Oct 21, 2025
Reiterates: Buy
Price Target: $62
Current: $30.27
Upside: +104.82%
Canaan
Oct 14, 2025
Reiterates: Buy
Price Target: $8
Current: $0.49
Upside: +1,530.66%
Viking Therapeutics
Sep 22, 2025
Reiterates: Buy
Price Target: $125
Current: $29.00
Upside: +331.03%
Jasper Therapeutics
Sep 22, 2025
Maintains: Buy
Price Target: $20 → $7
Current: $1.14
Upside: +514.04%
Sep 9, 2025
Reiterates: Buy
Price Target: $20
Current: $5.82
Upside: +243.64%
Dec 13, 2024
Initiates: Buy
Price Target: $42
Current: $26.72
Upside: +57.19%
May 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.39
Upside: -
Aug 15, 2023
Maintains: Buy
Price Target: $1,000 → $800
Current: $0.87
Upside: +91,422.71%
Aug 11, 2023
Maintains: Buy
Price Target: $85 → $91
Current: $32.28
Upside: +181.91%
Aug 10, 2023
Maintains: Buy
Price Target: $320 → $160
Current: $6.91
Upside: +2,215.48%
Jul 25, 2023
Initiates: Buy
Price Target: $16
Current: $1.98
Upside: +708.08%
Jun 13, 2023
Maintains: Buy
Price Target: $85 → $90
Current: $17.58
Upside: +411.95%
May 17, 2023
Initiates: Buy
Price Target: $31
Current: $8.31
Upside: +273.04%
Mar 28, 2023
Maintains: Buy
Price Target: $10 → $16
Current: $49.57
Upside: -68.73%
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $10
Current: $0.85
Upside: +1,076.47%